ER 50891 quarterhydrate is a potent antagonist of retinoic acid receptor alpha(RARalpha). ER 50891 quarterhydrate significantly attenuates ATRAs inhibitive effects on BMP 2-induced osteoblastogenesis[1].
Molecular Weight:
437.02
Purity:
99.61
Formula:
C29H24N2O2.1/4H20
Target:
RAR/RXR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted